EXACT Therapeutics and GE HealthCare Partner in Cancer Therapy

EXACT Therapeutics AS (DE:56F) has released an update.

Don't Miss our Black Friday Offers:

EXACT Therapeutics has secured a $7 million investment from GE HealthCare to advance its Acoustic Cluster Therapy (ACT) for pancreatic cancer. This strategic collaboration aims to support EXACT’s Phase 2 ENACT study and includes a four-year agreement for the development and supply of clinical equipment. The partnership highlights a significant step in therapeutic ultrasound, potentially transforming cancer treatment.

For further insights into DE:56F stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.